Male frontliner is 37th COVID-19 patient of Occidental Mindoro | Inquirer News

Male frontliner is 37th COVID-19 patient of Occidental Mindoro

By: - Correspondent / @mvirolaINQ
/ 03:12 PM May 30, 2020

CITY OF CALAPAN –– A 23-year-old male frontliner in Calintaan town in Occidental Mindoro province is the 37th confirmed coronavirus disease (COVID-19) case in the province, local authorities said Saturday.

The Provincial Health Office received the test result Saturday morning from the Philippine Red Cross, according to a post of the provincial government’s official Facebook account.

The patient underwent reverse transcription-polymerase chain reaction swab testing last May 28.

Article continues after this advertisement

He is asymptomatic and under isolation for monitoring.

Earlier, the province also recorded 26 new COVID-19 patients, who were construction workers from a Department of Public Works and Highways project in Magsaysay town.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, COVID-19, Philippine news updates, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.